Beaird Harris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.1K | Buy |
1,796
+114
| +7% | +$5.28K | 0.01% | 201 |
|
|
2025
Q1 | $103K | Buy |
1,682
+27
| +2% | +$1.65K | 0.01% | 167 |
|
|
2024
Q4 | $93.6K | Buy |
1,655
+1,228
| +288% | +$69.5K | 0.01% | 178 |
|
|
2024
Q3 | $22.1K | Sell |
427
-593
| -58% | -$30.6K | ﹤0.01% | 285 |
|
|
2024
Q2 | $42.4K | Buy |
1,020
+5
| +0.5% | +$208 | ﹤0.01% | 235 |
|
|
2024
Q1 | $55.1K | Buy |
1,015
+4
| +0.4% | +$217 | 0.01% | 197 |
|
|
2023
Q4 | $51.9K | Buy |
1,011
+3
| +0.3% | +$154 | 0.01% | 183 |
|
|
2023
Q3 | $58.5K | Buy |
1,008
+3
| +0.3% | +$174 | 0.01% | 164 |
|
|
2023
Q2 | $64.3K | Buy |
1,005
+3
| +0.3% | +$192 | 0.01% | 157 |
|
|
2023
Q1 | $69.5K | Sell |
1,002
-121
| -11% | -$8.39K | 0.01% | 149 |
|
|
2022
Q4 | $80.8K | Sell |
1,123
-75
| -6% | -$5.4K | 0.02% | 152 |
|
|
2022
Q3 | $85K | Buy |
1,198
+599
| +100% | +$42.5K | 0.02% | 124 |
|
|
2022
Q2 | $46K | Sell |
599
-594
| -50% | -$45.6K | 0.01% | 139 |
|
|
2022
Q1 | $87K | Buy |
1,193
+2
| +0.2% | +$146 | 0.03% | 147 |
|
|
2021
Q4 | $74K | Buy |
+1,191
| New | +$74K | 0.03% | 194 |
|